Skip to main content
. 2012 Feb 16;7(2):e29522. doi: 10.1371/journal.pone.0029522

Table 1. Baseline demographics of the COHORT population by group.

Groups that carry an expanded allele Groups that do not carry an expanded allele
Individuals with clinically diagnosed HD[n = 930] First-degree relatives who pursued genetic testing and carry an expanded allele[n = 248] First-degree relatives who did not pursue genetic testing and carry an expanded allele[n = 112] First-degreerelatives who did not pursue genetic testing and do not carry an expanded allele[n = 224] First-degree relatives who pursued genetic testing and do not carry an expanded allele[n = 41] Spousesand caregivers[n = 430] P-value*
Group definition
(CAG)n of 36 or greater Yes Yes Yes No No No -
Genetic testing pursued prior to baseline Some Yes No No Yes No -
Clinically diagnosed with HD Yes No No No No No -
Demographics
Age [years] 51.9 (12.0) 40.9 (12.5) 40.9 (12.9) 47.2 (14.3) 43.9 (12.2) 52.4 (12.3) <0.001
Female [%] 51.6 64.1 61.6 69.2 61.0 53.5 <0.001
White [%] 93.2 96.0 90.2 91.0 97.6 94.2 0.11
Ethnicity [% reporting Spanish origin] 3.9 4.4 1.8 4.5 4.9 4.7 0.82
Education [% completing high school or more] 89.4 90.7 88.4 93.7 73.2 90.7 0.004
Employment status [% currently in labor force] 16.8 68.6 72.3 74.4 65.9 66.5 <0.001
Marital status [% currently married] 60.2 62.1 56.3 60.1 61.0 89.5 <0.001

Values are listed as mean (standard deviation) unless otherwise noted.

COHORT = Cooperative Huntington Observational Research Trial; HD = Huntington disease; (CAG)n = cytosine-adenine-guanine repeat length in the Huntingtin allele; UHDRS = Unified Huntington's Disease Rating Scale.

*P-values refer to overall tests of heterogeneity across all six groups.